Cargando…
Memantine Attenuates Alzheimer’s Disease-Like Pathology and Cognitive Impairment
Deficiency of protein phosphatase-2A is a key event in Alzheimer’s disease. An endogenous inhibitor of protein phosphatase-2A, inhibitor-1, I(1) (PP2A), which inhibits the phosphatase activity by interacting with its catalytic subunit protein phosphatase-2Ac, is known to be upregulated in Alzheimer’...
Autores principales: | Wang, Xiaochuan, Blanchard, Julie, Grundke-Iqbal, Inge, Iqbal, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689401/ https://www.ncbi.nlm.nih.gov/pubmed/26697860 http://dx.doi.org/10.1371/journal.pone.0145441 |
Ejemplares similares
-
Dysregulation of Protein Phosphorylation/Dephosphorylation
in Alzheimer's Disease: A Therapeutic Target
por: Gong, Cheng-Xin, et al.
Publicado: (2006) -
CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer’s disease
por: Jin, Nana, et al.
Publicado: (2013) -
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention
por: Iqbal, K, et al.
Publicado: (2008) -
Young blood plasma reduces Alzheimer’s disease-like brain pathologies and ameliorates cognitive impairment in 3×Tg-AD mice
por: Zhao, Ying, et al.
Publicado: (2020) -
Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer’s Disease-Like Pathology and Cognitive Impairments
por: Mahaman, Yacoubou Abdoul Razak, et al.
Publicado: (2018)